Billiontoone Inc (BLLN) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Billiontoone Inc   (NASDAQ: BLLN)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Billiontoone Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Billiontoone Inc 's ROA in the third quarter of 2026?
Billiontoone Inc achieved a return on average assets (ROA) of 7 % in its third quarter of 2026, this is above BLLN's average return on assets of 0%.
Billiontoone Inc assets over the 12 months ending in its third quarter of 2026 are valued at $706 million

ROA has improved compared to 5.61% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector Billiontoone Inc achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the second quarter of 2026 at no. .

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Total Assets Change 132.2 % 89.02 % - - -
Y / Y Net Income Change 1054.01 % - -95.67 % -98.52 % -
Net Income (TTM) in million 49 34 25 423 821
Return On Assets (TTM) 7 % 5.61 % 4.93 % 125.58 % 460.33 %
BLLN's Total Ranking # # # # #
Total Assets (TTM) in million 760 730 701 633 328
Seq. Total Assets Change 4.22 % 4.13 % 10.76 % 93.16 % -15.16 %
Seq. Net Income Change 115.93 % -55.18 % 200.65 % 296.62 % -

BLLN's 5 Years Annual ROA >> Back to BLLN Management Effectiveness >> Compare BLLN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Assets Statistics
High Average Low
0 %
0 %
0 %
 





Financial Statements
Billiontoone Inc 's Assets $ 760 million BLLN's Balance sheet
Billiontoone Inc 's Income $ 17 million Quarterly BLLN's Income Statement
BLLN's Income by Division See BLLN's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
FY
FY
FY
FY
Y / Y Total Assets Change - - - - -
Total Assets in million 633 0 0 0 0
Y / Y Net Income Change - - - - -
Net Income in million 3 0 0 0 0
Annual Return On Assets 0.46 % - - - -

BLLN's 5 Years Annual ROA >> Back to BLLN Management Effectiveness >> Compare BLLN ROA to its Competitors



Comment on BLLN's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA deteriorated to 0.46 %, despite annual net income growth of % to $2.92 million, from $0.00 million a year ago, as BLLN's assets increase to $632.65 million, by %.


More Return On Assets Ratios
BLLN's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BLLN's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BLLN's Competitors
Subscribers only: Roa for Billiontoone Inc 's Suppliers
Subscribers only: Return On Assets for BLLN's Customers

You may also want to know
BLLN's Roi BLLN's Inventory Turnover Ratio BLLN's Growth Rates BLLN's Dividend Comparisons
BLLN's Profitability Ratios BLLN's Asset Turnover Ratio BLLN's Dividend Growth
BLLN's Roe BLLN's Valuation Ratios BLLN's Financial Strength Ratios BLLN's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA
Resmed Inc   18.67 %
Alector Inc   18.37 %
Corcept Therapeutics Inc  18.09 %
Chemed Corporation  17.73 %
Halozyme Therapeutics Inc   17.26 %
Pro dex Inc   16.75 %
Denali Therapeutics Inc   16.42 %
Krystal Biotech Inc   15.48 %
West Pharmaceutical Services Inc   15.47 %
Dexcom Inc   15.47 %
Intuitive Surgical Inc   14.71 %
Vertex Pharmaceuticals Inc  14.16 %
Neurocrine Biosciences Inc   13.69 %
Illumina Inc   13.43 %
Healthcare Services Group Inc   12.79 %
Kiniksa Pharmaceuticals International Plc  12.64 %
Tenet Healthcare Corp  12.39 %
Hca Healthcare Inc   11.73 %
Carlisle Companies Incorporated  11.72 %
Regeneron Pharmaceuticals Inc   11.50 %
Lantheus Holdings Inc   11.43 %
Msa Safety Inc  11.01 %
Encompass Health Corporation  10.99 %
Inspire Medical Systems inc   10.89 %
Transmedics Group Inc   10.67 %
Bristol myers Squibb Company  10.47 %
Lemaitre Vascular Inc   10.28 %
Bio rad Laboratories Inc   9.88 %
3m Company  9.60 %
Bioventus Inc   9.47 %

Date modified: 2026-11-06T13:07:13+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.